Pharmacology & Therapeutics

Papers
(The H4-Index of Pharmacology & Therapeutics is 65. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
WITHDRAWN: 17th International conference on bioactive lipids in cancer, inflammation and related diseases virtual special issue430
Measuring brain docosahexaenoic acid turnover as a marker of metabolic consumption315
Editorial Board309
Unlocking the power of affibody conjugated radioactive metallopharmaceuticals for targeted cancer diagnosis and therapy269
Non-canonical G protein signaling255
New therapeutic horizons for plasma phospholipid transfer protein (PLTP): Targeting endotoxemia, infection and sepsis240
Potential neonatal toxicity of new psychoactive substances220
Collateral lethality: A unique type of synthetic lethality in cancers209
Unfolded protein responses: Dynamic machinery in wound healing209
Inflammation, lipids, and pain in vulvar disease179
HIV-associated neurotoxicity and cognitive decline: Therapeutic implications175
In cancer, all roads lead to NADPH174
Efficacy and safety of immune-modulating therapy for primary sclerosing cholangitis: A systematic review and meta-analysis171
Exploiting the obesity-associated immune microenvironment for cancer therapeutics171
Matrikines in the skin: Origin, effects, and therapeutic potential154
Adenosine receptor signalling as a driver of pulmonary fibrosis151
Retinoid dynamics in vision: from visual cycle biology to retina disease treatments134
Endothelial dysfunction as a complication of anti-cancer therapy133
The role of macrophages in asthma-related fibrosis and remodelling130
Regulatory lipid vicinal diols counteract the biological activity of epoxy fatty acids and can act as biomarkers and mechanisms for disease progression128
Sulfoconjugation of protein peptides and glycoproteins in physiology and diseases125
Pharmacological modulation of respiratory control: Ampakines as a therapeutic strategy124
Boron in cancer therapeutics: An overview124
Sleep apnea and pulmonary hypertension: A riddle waiting to be solved120
Dysregulation of metabolic pathways in pulmonary fibrosis114
Imaging neuroinflammation with TSPO: A new perspective on the cellular sources and subcellular localization108
TAAR1 as an emerging target for the treatment of psychiatric disorders107
Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?103
Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics100
TLR4 biased small molecule modulators98
Is the peroxisome proliferator-activated receptor gamma a putative target for epilepsy treatment? Current evidence and future perspectives98
Myeloid cells in the era of cancer immunotherapy: Top 3 unanswered questions98
Management of drug-resistant hypertension as a heterogeneous disorder97
Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets95
Contribution of non-selective membrane channels and receptors in epilepsy94
The phospholipase A2 superfamily as a central hub of bioactive lipids and beyond92
Novel strategies and promising opportunities for targeted protein degradation: An innovative therapeutic approach to overcome cancer resistance90
Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches88
Cell-based therapies for vascular regeneration: Past, present and future87
Novel approaches to target fibroblast mechanotransduction in fibroproliferative diseases86
Bispecific antibodies for the treatment of neuroblastoma86
Corrigendum to “The role of CD71+ erythroid cells in the regulation of the immune response” [Pharmacology & Therapeutics 228 (2021) 107927]85
Editorial Board84
Review: Sex-related differences in the treatment of cardiac arrhythmia82
Natural products that alleviate depression: The putative role of autophagy82
Pharmacological treatment of cardiogenic shock – A state of the art review82
The pathomimetic oAβ25–35 model of Alzheimer's disease: Potential for screening of new therapeutic agents80
Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance80
Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression77
Recent advances in metabolism and toxicity of tyrosine kinase inhibitors75
Wnt signaling: A prospective therapeutic target for chronic pain74
Interactions between NSAIDs, opioids and the gut microbiota - Future perspectives in the management of inflammation and pain70
Therapeutic implications of impaired nuclear receptor function and dysregulated metabolism in Wilson's disease70
Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms69
Targeting Sirtuin1 to treat aging-related tissue fibrosis: From prevention to therapy69
PGRMC1: An enigmatic heme-binding protein69
G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs)69
Stabilizing the neural barrier – A novel approach in pain therapy68
Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases67
Entering the TiME machine: How age-related changes in the tumor immune microenvironment impact melanoma progression and therapy response67
A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathy67
HDL-based therapeutics: A promising frontier in combating viral and bacterial infections67
DNA methylation in cell plasticity and malignant transformation in liver diseases66
The role of microglia heterogeneity in synaptic plasticity and brain disorders: Will sequencing shed light on the discovery of new therapeutic targets?65
CircRNAs as upstream regulators of miRNA//HMGA2 axis in human cancer65
0.095235109329224